Furosemide

呋塞米

Report date: 2026/05/05 20:00:16
NME

Base Information

Drug NameFurosemide
Drug Alias NameFrusemide呋喃苯胺酸FurosemidaFurosemidumDiumide-K +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitorsGamma-aminobutyric acid A receptor antagonists
TargetsSodium-(potassium)-chloride cotransporter 2Gamma-aminobutyric acid A receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Acutely decompensated congestive heart failureSchizophrenia +[43] 
Global Approved IndicationsEdemaHypertension
Approved Indications in ChinaEdemaHypertension
Original Approved Country/TerritoryN/A
Original Approved Date1961/01/01
Country/TerritoryBelgiumCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Nacional De Cardiologia Ignacio ChavezSq Innovation IncUniversity of Texas Southwestern Medical Center +[15] 
Inactive CompaniesPharmobedient Consulting LLCUniversity Of Utah Center For Clinical And Translational ScienceJan Kochanowski University +[31] 
Active IndicationsAcutely decompensated congestive heart failureEdemaInflammation +[17] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)SchizophreniaPostoperative Complications +[26] 

Other Information

ATC CodeC03CA01
Related LinksWikipediaDrugBankKEGG